Literature DB >> 8305650

Baseline characteristics in the Modification of Diet in Renal Disease Study.

T Greene1, J J Bourgoignie, V Habwe, J W Kusek, L G Snetselaar, J M Soucie, M E Yamamoto.   

Abstract

The Modification of Diet in Renal Disease Study is randomized, multicenter, clinical trial designed to determine the effects of three levels of dietary control of protein and phosphorus and two levels of blood pressure control on the rate of decline of kidney function among persons with chronic renal disease. Study participants were assigned to one of two studies, Study A or Study B, depending on their GFR just before randomization. Within each study, participants were randomly allocated to one of two levels of blood pressure control and to one of two dietary interventions according to separate 2 x 2 factorial designs. A total of 840 men and women aged 18 to 70 were randomized. This report summarizes the demographic, biochemical, and clinical characteristics of the randomized participants at the time of entry into the trail, overviews the protocol and purposes of the baseline period before randomization, and evaluates the balance among the treatment intervention groups within Studies A and B at the time of randomization. Major indicators of renal function were found to be well balanced among the treatment groups. Selected baseline characteristics of participants in the Modification of Diet in Renal Disease Study are compared with those of other renal clinical trials and with those of new cases of treated ESRD reported in the United States Renal Data System.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305650     DOI: 10.1681/ASN.V451221

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

Review 1.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

2.  Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Authors:  Jiun-Ruey Hu; Josef Coresh; Lesley A Inker; Andrew S Levey; Zihe Zheng; Casey M Rebholz; Adrienne Tin; Lawrence J Appel; Jingsha Chen; Mark J Sarnak; Morgan E Grams
Journal:  Kidney Int       Date:  2018-06-02       Impact factor: 10.612

3.  Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease.

Authors:  Varun Chawla; Tom Greene; Gerald J Beck; John W Kusek; Allan J Collins; Mark J Sarnak; Vandana Menon
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 8.237

4.  The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease.

Authors:  Casey M Rebholz; Aditya Surapaneni; Andrew S Levey; Mark J Sarnak; Lesley A Inker; Lawrence J Appel; Josef Coresh; Morgan E Grams
Journal:  J Nutr       Date:  2019-04-01       Impact factor: 4.798

5.  A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease.

Authors:  Jiun-Ruey Hu; Leslie Myint; Andrew S Levey; Josef Coresh; Lesley A Inker; Morgan E Grams; Eliseo Guallar; Kasper D Hansen; Eugene P Rhee; Tariq Shafi
Journal:  Kidney Int       Date:  2021-11-26       Impact factor: 10.612

6.  Comparison of Influence of Blood Pressure and Carotid-Femoral Pulse Wave Velocity on Target Organ Damage in Hypertension.

Authors:  Huijuan Chao; Yan He; Qian Wang; Yaya Bai; Alberto Avolio; Xueqin Deng; Junli Zuo
Journal:  Front Cardiovasc Med       Date:  2022-07-05

7.  Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

Authors:  Xun Liu; Meredith C Foster; Hocine Tighiouart; Amanda H Anderson; Gerald J Beck; Gabriel Contreras; Josef Coresh; John H Eckfeldt; Harold I Feldman; Tom Greene; L Lee Hamm; Jiang He; Edward Horwitz; Julia Lewis; Ana C Ricardo; Haochang Shou; Raymond R Townsend; Matthew R Weir; Lesley A Inker; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2016-09-20       Impact factor: 8.860

8.  Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).

Authors:  Richard Haynes; Natalie Staplin; Jonathan Emberson; William G Herrington; Charles Tomson; Lawrence Agodoa; Vladimir Tesar; Adeera Levin; David Lewis; Christina Reith; Colin Baigent; Martin J Landray
Journal:  Am J Kidney Dis       Date:  2014-03-05       Impact factor: 8.860

9.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2018-10-04

10.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2020-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.